Brought to you by 
Watson buys CoCensys' sales division and its products
10 Apr 2001
Executive Summary
Watson Laboratories (generics, niche drugs) bought the assets of CoCensys' (central nervous system disorders) pharmaceutical sales and marketing division, with its newly acquired CNS product (sales of $5mm) and two co-promotion contracts.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Watson buys CoCensys' sales division and its products
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice